Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Retatrutide (LY3437943) is a first-in-class triple-receptor agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
European Journal of Endocrinology
Exceptions like BPC-157 and 5-Amino-1MQ have specific formulations designed for oral stability
5 Benefits and Side Effects If you have low energy, feel stuck in a mental haze, or have trouble losing weight, youre in good company
Let both air-dry for at least 2030 seconds
Mechanism of Action Stimulates lipolysis via 3-adrenergic receptor-like activation
US$ 26.24
US$ 23.27
US$ 20.99
US$ 23.68
US$ 26.02
US$ 27.33
US$ 21.96
